Gene · 442891
Papers2,355
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,355
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action. | Front Pharmacol | 2023 | 37693915 | PubTator, text mining | PubMed |
| MicroRNAs as the critical regulators of Forkhead box protein family during gynecological and breast tumor progression and metastasis. | Eur J Med Res | 2023 | 37689738 | PubTator, text mining | PubMed |
| The Regulation of Ferroptosis by Noncoding RNAs. | Int J Mol Sci | 2023 | 37686142 | PubTator, text mining | PubMed |
| Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinoma. | Oncol Lett | 2023 | 37664650 | PubTator, text mining | PubMed |
| Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37664153 | PubTator, text mining | PubMed |
| Research progress in the mechanism and treatment of osteosarcoma. | Chin Med J (Engl) | 2023 | 37649421 | PubTator, text mining | PubMed |
| Effect of the MiR-99b and MiR-135b on peritoneal carcinomatosis and liver metastasis in colorectal cancer. | Clinics (Sao Paulo) | 2023 | 37639911 | PubTator, text mining | PubMed |
| Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles. | Front Oncol | 2023 | 37637043 | PubTator, text mining | PubMed |
| Natural Products Treat Colorectal Cancer by Regulating miRNA. | Pharmaceuticals (Basel) | 2023 | 37631037 | PubTator, text mining | PubMed |
| Expression of HOXA10 Gene in Women with Endometriosis: A Systematic Review. | Int J Mol Sci | 2023 | 37629050 | PubTator, text mining | PubMed |
| The Bone Microenvironment Soil in Prostate Cancer Metastasis: An miRNA Approach. | Cancers (Basel) | 2023 | 37627055 | PubTator, text mining | PubMed |
| ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See! | Biomedicines | 2023 | 37626796 | PubTator, text mining | PubMed |
| Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer. | Biomedicines | 2023 | 37626731 | PubTator, text mining | PubMed |
| The potential of using non-coding RNAs in forensic science applications. | Forensic Sci Res | 2023 | 37621455 | PubTator, text mining | PubMed |
| Expression status of circ-SMARCA5, circ-NOL10, circ-LDLRAD3, and circ-RHOT1 in patients with colorectal cancer. | Sci Rep | 2023 | 37587156 | PubTator, text mining | PubMed |
| Genome-wide RNA-sequencing dataset reveals AC096751.1 sever as a novel prognostic long non-coding RNA and its potential molecular mechanisms in patients with colon adenocarcinoma. | J Cancer | 2023 | 37576398 | PubTator, text mining | PubMed |
| Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice. | Cancers (Basel) | 2023 | 37568746 | PubTator, text mining | PubMed |
| Functional In Vivo Screening Identifies microRNAs Regulating Metastatic Dissemination of Prostate Cancer Cells to Bone Marrow. | Cancers (Basel) | 2023 | 37568709 | PubTator, text mining | PubMed |
| Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches. | J Clin Med | 2023 | 37568452 | PubTator, text mining | PubMed |
| Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation. | Front Immunol | 2023 | 37564645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442891/papers?page=7